Abstract
Epidemiologic case-study and cohort-study data concerning effects of estrogen replacement therapy on the risk of cardiovascular disease in postmenopausal women are reviewed. Although there is conflicting literature, most research strongly suggests that estrogens, and estrogen replacement therapy in particular, reduce the risk of cardiovascular disease. Such reduced risk in estrogen users is most likely mediated in part by the beneficial effects of estrogen therapy on lipid metabolism. Risks associated with the use of estrogens and possible effects when progestational agents are added to an estrogen regimen are also discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Gynecology and Obstetrics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
